What is the prevalence of Propionic Acidemia?

Propionic acidemia is a rare, life-threatening metabolic disorder with an estimated global incidence ranging from 1 in 50,000 to 1 in 250,000 live births, though rates vary significantly by region. Because it is a multisystem condition often requiring specialized metabolic testing, the true prevalence remains difficult to capture, as many individuals may go undiagnosed or be misdiagnosed in regions without robust newborn screening programs.

Is Propionic acidemia considered a common or rare disease?

Propionic acidemia is classified as an ultra-rare genetic metabolic disorder. It is an organic acidemia caused by a deficiency of the enzyme propionyl-CoA carboxylase. Because the condition is rare, clinical data is often derived from registries rather than large-scale epidemiological studies. Within the DiseaseMaps.org community, 17 individuals have connected to share their experiences with Propionic acidemia, providing a vital, real-world perspective on living with this complex condition that often goes beyond what is found in clinical literature.

What is the estimated incidence and geographic distribution of Propionic acidemia?

The incidence of Propionic acidemia shows marked geographic and ethnic variation. While the global average is often cited between 1:50,000 and 1:250,000, specific populations show much higher frequencies due to founder effects and higher rates of consanguinity. For example, in Saudi Arabia, the incidence has been reported as high as 1 in 2,000 to 1 in 5,000. In contrast, in many Western countries, the introduction of expanded newborn screening has improved early detection, though the condition remains rare. It is important to note that these figures are estimates; accurate global prevalence is challenging to determine because some cases result in early neonatal mortality before a formal diagnosis is confirmed.

Does Propionic acidemia affect males and females differently?

Propionic acidemia is inherited in an autosomal recessive pattern, meaning it affects males and females with equal frequency. There is no evidence of gender-based predilection for the disease. Regarding age of onset, the condition is typically characterized by two primary presentations:

• Neonatal onset: Often presents in the first few days of life with severe metabolic acidosis, lethargy, and poor feeding.


• Late-onset (infantile or childhood): Can present later with intermittent episodes of metabolic decompensation, developmental delays, or neurological symptoms.

Why is accurate prevalence data for Propionic acidemia difficult to obtain?

The primary challenge in establishing the true prevalence of Propionic acidemia is underdiagnosis and diagnostic delay. In many parts of the world, newborn screening programs do not include tandem mass spectrometry, which is required to detect the elevated levels of propionylcarnitine indicative of Propionic acidemia. Furthermore, because symptoms can be non-specific—mimicking conditions like sepsis or other metabolic disorders—some patients may be misdiagnosed or pass away before the correct metabolic testing is performed. Consequently, clinical researchers believe the current statistical estimates may underrepresent the actual number of individuals living with the disorder.

Next steps

• Consult with a board-certified metabolic geneticist to review diagnostic testing options or confirm a suspected diagnosis.


• Request a referral to a metabolic dietitian, as specialized low-protein medical nutrition is the cornerstone of managing Propionic acidemia.


• Connect with the DiseaseMaps.org community to engage with other families and patients who understand the daily challenges of managing this rare condition.


• Stay informed about clinical trials and emerging therapies through resources like the NIH Genetic and Rare Diseases Information Center (GARD).

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Propionic acidemia.


• Orphanet: Propionic acidemia (ORPHA:73).


• OMIM (Online Mendelian Inheritance in Man): Propionic Acidemia; PA (Entry #606054).


• Journal of Inherited Metabolic Disease: Global epidemiology and newborn screening data for organic acidemias.